Purchase Order 15DDL124P00000013
- Not listed
- The U.S. Drug Enforcement Administration (DEA) awarded a $117,910.00 Firm Fixed Price purchase order to Cayman Chemical Co Inc., a for-profit manufacturer of biochemicals and research tools located in Ann Arbor, Michigan. The contract is for the procurement of 16 substances to support the DEA's drug enforcement activities, with a period of performance ending on April 29, 2025. Cayman Chemical has a history of securing federal contracts from agencies such as the Defense Health Agency, Centers for...
- This is a $27,350.00 firm fixed price purchase order awarded to Cayman Chemical Co Inc. by the Drug Enforcement Administration (DEA) on August 1, 2024. The contract is for the purchase of three substances to be used in testing, with a delivery date of December 20, 2024. Cayman Chemical Co Inc. is a leading supplier of biochemical products and research tools to federal agencies, specializing in the production of high-quality chemicals, assay kits, antibodies, and recombinant proteins. The company...
- The U.S. Drug Enforcement Administration (DEA) awarded a firm-fixed-price purchase order contract to Cayman Chemical Co Inc., a leading supplier of biochemical products and research tools, for the delivery of DEA-19 RMP CAYMAN 07192024 reference materials. The $31,179 contract, with a completion date of September 30, 2024, does not utilize a set-aside designation. Cayman Chemical, a for-profit manufacturer, has a strong track record of providing specialized chemicals, assay kits, and other...
- This is a $24,069 firm-fixed-price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a manufacturer of biochemical products and research tools. The contract supports the DEA's drug enforcement and analysis efforts by providing reference materials, analytical standards, and specialized reagents. Cayman Chemical has an established track record of supplying the DEA and other federal agencies, such as the Centers for Disease Control and Prevention...
- This is a $19,153.30 firm fixed-price purchase order awarded to Cayman Chemical Co Inc., a manufacturer of biochemicals, assay kits, and other chemical products. The order is for the Drug Enforcement Administration and has a delivery date of April 30, 2024. Cayman Chemical has provided similar products and services to federal agencies like the CDC and Department of Defense in support of drug enforcement operations, forensic analysis, and substance abuse prevention efforts. The company has...
- The Department of Justice Drug Enforcement Administration awarded a $21,655 purchase order to Cayman Chemical Co Inc. to provide reference materials for use in evidence analysis, method development, and method verification. The contract has a period of performance from August 2, 2023 through August 1, 2024 and utilizes a firm fixed price arrangement. Cayman Chemical will deliver the reference materials to sites in Sterling, Virginia to support the DEA's efforts in forensic analysis and...
- The Department of Justice Drug Enforcement Administration awarded a $30,300 firm fixed price purchase order to Cayman Chemical Co Inc. to process an order for six controlled substances through January 2025. The award stems from a January 2024 special notice requesting synthetic substances for pharmacological testing to support the Drug and Chemical Evaluation Section's work in gathering information on drugs of concern and potentially schedule substances not currently controlled. Cayman...
- This is a federal delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Cayman Chemical Co Inc. for the provision of DLS Traceable Opioid Kits. The contract is a firm fixed-price award with a ceiling value of $499,800.00 and a period of performance through September 28, 2023. Cayman Chemical Co Inc. is a leading supplier of biochemical products and research tools, with a focus on supporting government agencies in areas such as drug enforcement, public...
- This is a contract awarded by the NIAID DEA OA Acquisitions division of the Department of Health and Human Services (HHS) to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools. The contract is for the purchase of a PRECELLYS MINILYS-PERSONAL TISSUE HOMOGEIZER, catalog# 10435, with a ceiling value of $3,781.00. It is a firm fixed price purchase order with a completion date of February 18, 2012. The contract does not have a set-aside designation. Cayman...
- The Drug Enforcement Administration awarded a firm fixed-price purchase order valued at $15,384.26 to EMD Millipore Corp (doing business as Milliporesigma) on February 1, 2026, for the procurement of laboratory products and services under the MILLIPORE SIGMAFY2026 contract. The performance period runs from February 1, 2026, through January 1, 2027, with work to be performed at the contractor's facility in Burlington, Massachusetts. This award represents a competitive procurement with no...
This is a purchase order awarded by the Department of Justice Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a manufacturer of biochemical products located in Ann Arbor, Michigan. The contract has a firm fixed price of $20,364.00 and a completion date of September 30, 2024. The contract is to provide the DEA with specialized reagents, test kits, and analytical standards to support the agency's work related to the opioid epidemic. Cayman Chemical is a well-established federal contractor, having previously provided similar supplies and services to agencies such as the Centers for Disease Control and Prevention, the Department of the Army, and the National Institutes of Health. There is no set-aside designation for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 4/5/24 |